ERFSF (Eurofins Scientific SE) Moat Score: 6/10 (As of Jun. 27, 2026)


ERFSF Eurofins Scientific SE ERFSF
79 GF Score
Price $79.77
GF Value $75.93
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Eurofins Scientific SE Moat Score?

Eurofins Scientific SE ERFSF +3.01% 79 Moat Score is 6 as of Jun. 27, 2026. GuruFocus rates ERFSF with a GF Score™ of 79/100 and a GF Value™ of $75.93 (Fairly Valued). The stock has 7 warning signs investors should review. Among 217 Medical Diagnostics & Research companies, Eurofins Scientific SE ranks better than 94.01% on this metric.

Eurofins Scientific SE has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Eurofins Scientific SE has Narrow Moat: Eurofins Scientific SE benefits from a strong brand and extensive network of laboratories, providing some customer loyalty and switching costs. Its proprietary technology and consistent R&D efforts contribute to its competitive position, but the market remains competitive, limiting a wider moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Eurofins Scientific SE might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Eurofins Scientific SE  (OTCPK:ERFSF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Eurofins Scientific SE Moat Score Related Terms

ERFSF vs TMO, DHR, IDXX: Moat Score Comparison

For the Diagnostics & Research subindustry, Eurofins Scientific SE's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eurofins Scientific SE Moat Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Moat Score distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's Moat Score falls into.


ERFSF
79GF Score
Eurofins Scientific SE ERFSF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Eurofins Scientific SE (ERFSF) has a Moat Score of 6 as of Jun. 27, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Eurofins Scientific SE ranks #13 out of 217 companies in the Medical Diagnostics & Research industry, placing it in the top 6%.
Is Eurofins Scientific SE's Moat Score too high?
Eurofins Scientific SE's current Moat Score is 6. Based on the distribution chart, Eurofins Scientific SE ranks #13 out of 217 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Eurofins Scientific SE has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Moat Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Eurofins Scientific SE ranks #13 out of 217 companies for Moat Score. This places Eurofins Scientific SE in the top 6% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Diagnostics & Research company?
A good Moat Score depends on the Medical Diagnostics & Research industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Eurofins Scientific SE's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $75.93, compared to a current price of $79.77 — trading 5.1% above its estimated fair value. The current Moat Score is 6. Eurofins Scientific SE's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current Moat Score is 6 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?

Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued. The current stock price of $79.77 is trading 5.1% above its estimated GF Value™ of $75.93. GuruFocus considers Eurofins Scientific SE to be Fairly Valued.

Key valuation signals for ERFSF:

  • Moat Score: 6
  • GF Value™: $75.93 vs. price of $79.77 (5.1% above fair value)
  • GF Score™: 79/100 with 7 warning signs

No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eurofins Scientific SE Business Description

Address 23 Val Fleuri, Luxembourg, LUX, 1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
79GF Score

Get the complete analysis for ERFSF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$79.77
Price
$75.93
GF Value